Tesamorelin price searches lead to two very different products. Egrifta WR is an FDA-approved prescription medicine made by Theratechnologies. Research-grade tesamorelin is a lyophilized peptide sold for laboratory research use only. They sit in different regulatory categories, and their prices are set in different ways. This page covers what is published for each as of November 17, 2026, and what US research suppliers listed that day.
Quick answer: There is no manufacturer list price for Egrifta WR on the Theratechnologies pages we could reach. Research-grade tesamorelin, a different product category, listed at $35.00–$120.00 per 10 mg vial at the US suppliers we checked on November 17, 2026. Vitrapep lists 5 mg at $69.99.
Two products, two categories
Tesamorelin is a synthetic analog of human growth hormone-releasing factor. It is made of the 44-amino-acid sequence of human GRF with a hexenoyl group attached to the tyrosine at the N-terminal end, and it is prepared as an acetate salt (DailyMed, 2025). It was studied in people with HIV in a randomized trial published in 2007 (Falutz et al., 2007). Our tesamorelin research guide covers that history.
- Prescription medicine. Egrifta WR is FDA-approved, manufactured under drug rules and dispensed by a pharmacy on a prescription. Its price depends on the pharmacy, the insurance plan and any manufacturer program.
- Research reagent. Research-grade tesamorelin is a lyophilized powder sold for laboratory work. FDA has not reviewed it as a drug. It is for laboratory research use only, not for human or veterinary use.
One is not a substitute for the other. The prices in this article describe two separate markets, not a choice between them. Our explainer on research use only labeling covers what that label means.
Egrifta WR: approval and published cost
The tesamorelin biologics license, BLA 022505, was first approved on November 10, 2010, for the original Egrifta product (FDA, Drugs@FDA). FDA records show a supplement to that license approved on March 25, 2025 (openFDA), and the Egrifta WR label carries a revision date of March 2025. The label states that Egrifta WR is indicated for the reduction of excess abdominal fat in HIV-infected adult patients with lipodystrophy, and that it is not indicated for weight management (DailyMed, 2025).
On price, the public record is thin:
- No published list price. We found no list price or wholesale acquisition cost for Egrifta WR on any Theratechnologies page we could load on November 17, 2026.
- Third-party figures vary widely. Discount-card and pharmacy sites quote numbers that differ by several times. They are not manufacturer sources, so we do not repeat them here.
- What a person pays for a prescription medicine depends on the dispensing pharmacy, insurance coverage and any manufacturer support program. Those terms come from the pharmacy and the manufacturer, not from a research supplier.
Research-grade tesamorelin prices at US suppliers
We checked supplier product pages on November 17, 2026, and recorded the listed single-vial price. Prices exclude shipping, codes and pack discounts.
Research-grade tesamorelin prices at US suppliers, checked November 17, 2026
| Supplier | Vial size | Listed price | Price per mg |
|---|---|---|---|
| MyPurePeptide | 10 mg | $35.00 | $3.50 |
| MyPurePeptide | 20 mg | $75.00 | $3.75 |
| Purgo Labs (listed as “Tesamorlin”) | 10 mg | $69.99 | $7.00 |
| Core Peptides | 5 mg | $43.00 | $8.60 |
| Core Peptides | 10 mg | $79.00 | $7.90 |
| Zeptix Labs | 10 mg | $99.99 | $10.00 |
| American Peptides (listed as AP-TESA, code TH9507) | 10 mg | $120.00 | $12.00 |
| Vitrapep | 5 mg | $69.99 | $14.00 |
Sources: supplier product pages listed in the references, read November 17, 2026. Price per mg is the listed price divided by the vial size. MyPurePeptide showed a struck-through price of $40.00 on its 10 mg vial, and Zeptix Labs showed $129.99 struck through on its 10 mg vial and was running a buy-one-get-one offer. Purgo Labs offered $52.49 with a first-order code. Core Peptides shows a $43.00–$79.00 range; the per-size prices come from its discount table. The American Peptides page does not use the name tesamorelin.
Two things stand out. The spread is wide: 10 mg vials ran from $35.00 to $120.00, more than a threefold gap for the same labeled amount. And Vitrapep’s price per mg is the highest in the table, because it sells a 5 mg vial only, and small vials carry more fixed cost per mg.
What drives the tesamorelin price spread
Our peptide prices explainer covers these levers across the catalog. For tesamorelin they work like this:
- Length. At 44 residues, tesamorelin is long for a research peptide. Solid-phase synthesis adds one amino acid at a time, and every coupling step loses some yield, so long chains cost more per mg (Verlander, 2007).
- The N-terminal modification. The hexenoyl group is what distinguishes tesamorelin from the unmodified GRF sequence. Adding it is an extra chemical step with its own purification.
- Purity and outside testing. HPLC purity and mass spectrometry identity from an outside laboratory, tied to the specific lot, are a real cost per batch. Laboratories accredited to ISO/IEC 17025 have been assessed for testing competence.
- Vial size. Filling, sealing, labeling and lot testing cost about the same for a 5 mg or a 20 mg vial, so larger vials cost less per mg.
- Promotions. Struck-through prices, buy-one-get-one offers and first-order codes move the effective price from week to week.
What to check before trusting a low price
- The compound name. If the product page and the certificate do not name tesamorelin, or misspell it, identity cannot be checked against the label.
- A lot-specific certificate. It should name the lot, the testing laboratory, the test date, HPLC purity and a mass spectrometry result that matches tesamorelin’s molecular weight of 5,135.9 Da as the free base (DailyMed, 2025). Our guide to reading a certificate of analysis walks through each field.
- Prices far below the rest. A low price is not proof of a problem, but it leaves less room for outside testing on every lot.
- Human-use language. A research listing should carry no dosing or human-use instructions. Its label should say research use only.
What Vitrapep charges for tesamorelin
Vitrapep lists tesamorelin as a 5 mg lyophilized vial at $69.99, or $14.00 per mg. Store prices may still change before launch. The product page lists the sequence, molecular formula and how to look up each lot’s test report. It is a research reagent, sold for laboratory research use only and not for human or veterinary use. It is not Egrifta WR and not a substitute for any prescription medicine. For sourcing questions, see where to buy tesamorelin.

Tesamorelin
Specifications and the current lot’s test documentation for the tesamorelin sold for laboratory research.
Frequently asked questions about tesamorelin price
How much does tesamorelin cost?
It depends on the product. Egrifta WR, the prescription medicine, had no manufacturer list price on the pages we could load on November 17, 2026. Research-grade tesamorelin listed at $35.00 to $120.00 per 10 mg vial at the US suppliers we checked, or $3.50 to $12.00 per mg.
What is Egrifta WR approved for?
Its label states that it is indicated for the reduction of excess abdominal fat in HIV-infected adult patients with lipodystrophy, and that it is not indicated for weight management (DailyMed, 2025).
Is research-grade tesamorelin the same as Egrifta WR?
No. Egrifta WR is an FDA-approved prescription medicine, manufactured and tested under drug rules and dispensed by a pharmacy. Research-grade tesamorelin is a laboratory reagent that FDA has not reviewed as a drug. It is for laboratory research use only, not for human or veterinary use, and it is not a substitute for any prescription medicine.
Why does tesamorelin cost more than many short peptides?
It is 44 amino acids long and carries an N-terminal hexenoyl modification. Longer sequences take more synthesis steps and more purification, and the modification adds a step. Both raise the cost per mg.
Why is a 5 mg vial more expensive per mg than a 10 mg vial?
Filling, sealing, labeling and lot testing cost about the same regardless of vial size. In a smaller vial, those costs are spread over fewer milligrams. Core Peptides, for example, listed $8.60 per mg at 5 mg and $7.90 per mg at 10 mg on November 17, 2026.
What to know now
- Egrifta WR is a prescription medicine. Its license dates to November 10, 2010, and its label was revised in March 2025.
- No published list price. No Theratechnologies page we could load on November 17, 2026, showed one.
- Research-grade 10 mg vials listed at $35.00–$120.00. That is $3.50 to $12.00 per mg across the US suppliers we checked.
- Vitrapep lists 5 mg at $69.99. At $14.00 per mg, it is the highest per-mg price in our table.
- Check identity before price. A named compound and a lot-specific certificate matter more than a discount.
What we’re watching
First, whether Theratechnologies publishes pricing for Egrifta WR on its product site once it loads again. Second, the wide spread in research-grade listings, where 10 mg vials ranged more than threefold on the same day. Third, naming practices, since several listings use codes or misspellings instead of the compound name. We will re-check these prices as they change.